MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation ROCE Ratio 2011-2026 | BSX
Annual ROCE Ratio Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.91 | 11.96 | 12.0 | 9.38 | 7.21 | -0.52 | 6.77 | 10.54 | 11.44 | 9.09 | 6.3 | 6.35 | 5.99 | 6.05 | 8.82 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.91 | -0.52 | 8.42 |
Quarterly ROCE Ratio Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.82 | 13.89 | 13.59 | 13.11 | 12.39 | 12.93 | 11.61 | 9.97 | 9.6 | 7.27 | 9.62 | 9.94 | 9.13 | 6.35 | 5.01 | 1.32 | -0.78 | -0.85 | 1.91 | 6.01 | 9.24 | 9.43 | 13.87 | 15.56 | 17.28 | 13.6 | 18.98 | 19.91 | 18.63 | 13.78 | 18.94 | 18.74 | 10.57 | 4.56 | -0.17 | -10.07 | -1.65 | -0.89 | 0.11 | 5.83 | 1.29 | 2.97 | 4.55 | 5.13 | 9.57 | -0.11 | -8.75 | -18.97 | -74.55 | -58.01 | -56.47 | -46.29 | 8.01 | 6.46 | 1.53 | 2.09 | 2.84 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.91 | -74.55 | 2.55 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M |  USA |
 |
LivaNova PLC
LIVN
|
16.62 | $ 69.84 | 1.14 % | $ 3.79 B |  Britain |
 |
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
6.76 | $ 6.61 | 3.44 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-89.32 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
-660.94 | $ 13.85 | -0.57 % | $ 2.08 B | USA |
 |
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
-6.09 | $ 31.25 | -3.85 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
79.08 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-64.64 | $ 3.46 | -2.26 % | $ 120 M | USA |
 |
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
4.09 | $ 269.55 | 0.25 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
-3.22 | $ 4.63 | 3.58 % | $ 173 M |  France |
 |
Bruker Corporation
BRKR
|
14.21 | $ 39.92 | 0.38 % | $ 5.95 K | USA |
 |
BioSig Technologies
BSGM
|
978.11 | - | 37.08 % | $ 85.7 M | USA |
 |
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
-77.77 | $ 15.18 | 4.3 % | $ 410 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
9.93 | $ 46.01 | -0.07 % | $ 1.43 B | USA |
 |
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.35 | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
12.27 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Cutera
CUTR
|
-60.43 | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-18.05 | $ 10.16 | 2.11 % | $ 290 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-110.81 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
22.36 | $ 23.53 | 1.64 % | $ 199 M | USA |
 |
Second Sight Medical Products
EYES
|
-140.13 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-94.15 | $ 77.39 | -2.87 % | $ 2.18 B |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
-28.95 | $ 2.46 | 1.23 % | $ 144 M | Israel |
 |
GBS
GBS
|
-355.28 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
2.84 | $ 18.54 | -0.16 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
10.49 | $ 95.57 | 3.99 % | $ 12.9 B | USA |
 |
Profound Medical Corp.
PROF
|
-18.9 | $ 7.35 | 2.79 % | $ 180 M | Canada |
 |
Helius Medical Technologies
HSDT
|
-528.85 | $ 2.18 | 17.84 % | $ 1.33 M | USA |
 |
IRadimed Corporation
IRMD
|
25.3 | $ 100.38 | 1.3 % | $ 1.27 B | USA |
 |
Invacare Corporation
IVC
|
-99.23 | - | - | $ 24.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.84 | $ 11.54 | 0.09 % | $ 889 M | USA |
 |
Inogen
INGN
|
-24.45 | $ 6.07 | 3.94 % | $ 144 M | USA |